Health Ensartinib Tops Crizotinib in ALK-Positive NSCLC Jason Junior Sep 3, 2021 The investigational ALK inhibitor ensartinib demonstrated better efficacy than crizotinib (Xalkori) against systemic and intracranial disease in…